Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

Drug for Enlarged Prostate May Slow Cancer Growth

Could Avodart Be an Alternative to Surgery, Radiation for Low-Risk Prostate Cancer?

Avodart-Treated Patients Less Anxious

Roughly half the men in the study took the prostate drug for three years while the other half took placebo pills.

Biopsies were performed after 18 months and three years to measure disease progression, and the men completed questionnaires about how anxious they were about their cancer.

Men treated with Avodart reported significantly less cancer-related anxiety.

They were also more likely to have delayed prostate cancer progression and show no evidence of cancer on their final biopsy.

The Avodart-treated patients did experience more drug-related side effects (24% vs. 15%), consisting mainly of sexual dysfunction.

The study was funded by Avodart manufacturer GlaxoSmithKline, and the company was also involved in its design, Fleshner says.

It appears this week in the online edition of the journal The Lancet.

‘More Study Needed to Prove Benefit’

Fleshner says the fact that significantly fewer men who took Avodart chose to have surgery or radiation shows a "real world" benefit for the treatment.

But Brooks says the study was not large enough or the follow-up long enough to prove that the drug improves long-term outcomes in patients with low-risk prostate cancers.

He agrees that drug treatments that clearly affect disease progression could convince more low-risk patients to forgo surgery or radiation.

“Unfortunately, I don’t think we can put this drug in that category yet,” he tells WebMD.

“With or without a drug treatment, we now know that active surveillance is a reasonable approach for many men with low-risk prostate cancers,” Brooks says.

“We now have relatively well-defined criteria to tell us when active surveillance is appropriate and reasonable protocols to help us follow men who choose this path.”

1 | 2

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D